ATE428312T1 - Verwendung von ginkgokomplexen zur verbesserung von kognitiven leistungen und linderung der mentalen ermüdung - Google Patents

Verwendung von ginkgokomplexen zur verbesserung von kognitiven leistungen und linderung der mentalen ermüdung

Info

Publication number: ATE428312T1
Authority: AT; Austria
Prior art keywords: mental fatigue; ginkgo; memory; relief; improve
Prior art date: 2004-01-29

Application number

AT04001937T

Other languages

English (en)

Inventor

Paolo Morazzoni

Orlando Petrini

Andrew Scholey

David Kennedy

Original Assignee

Indena Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-01-29

Filing date

2004-01-29

Publication date

2009-05-15

2004-01-29 Application filed by Indena Spa filed Critical Indena Spa

2009-05-15 Application granted granted Critical

2009-05-15 Publication of ATE428312T1 publication Critical patent/ATE428312T1/de

Links

241000218628 Ginkgo Species 0.000 title abstract 3
235000011201 Ginkgo Nutrition 0.000 title abstract 3
235000008100 Ginkgo biloba Nutrition 0.000 title abstract 3
208000019914 Mental Fatigue Diseases 0.000 title abstract 3
230000003931 cognitive performance Effects 0.000 title 1
230000003920 cognitive function Effects 0.000 abstract 3
TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 abstract 2
ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 abstract 2
208000024827 Alzheimer disease Diseases 0.000 abstract 1
206010012289 Dementia Diseases 0.000 abstract 1
230000001149 cognitive effect Effects 0.000 abstract 1
230000003247 decreasing effect Effects 0.000 abstract 1
230000006866 deterioration Effects 0.000 abstract 1
235000015872 dietary supplement Nutrition 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
206010016256 fatigue Diseases 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
230000036651 mood Effects 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Natural Medicines & Medicinal Plants (AREA)
Bioinformatics & Cheminformatics (AREA)
Botany (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Nutrition Science (AREA)
Biomedical Technology (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT04001937T 2004-01-29 2004-01-29 Verwendung von ginkgokomplexen zur verbesserung von kognitiven leistungen und linderung der mentalen ermüdung ATE428312T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP04001937A EP1559430B1 (de)	2004-01-29	2004-01-29	Verwendung von Ginkgokomplexen zur Verbesserung von kognitiven Leistungen und Linderung der mentalen Ermüdung

Publications (1)

Publication Number	Publication Date
ATE428312T1 true ATE428312T1 (de)	2009-05-15

Family

ID=34639409

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04001937T ATE428312T1 (de)	2004-01-29	2004-01-29	Verwendung von ginkgokomplexen zur verbesserung von kognitiven leistungen und linderung der mentalen ermüdung

Country Status (19)

Country	Link
US (1)	US8591965B2 (de)
EP (1)	EP1559430B1 (de)
JP (1)	JP5300196B2 (de)
KR (2)	KR101249667B1 (de)
CN (1)	CN1913907B (de)
AT (1)	ATE428312T1 (de)
AU (1)	AU2005210091B2 (de)
CA (1)	CA2554760C (de)
DE (1)	DE602004020574D1 (de)
DK (1)	DK1559430T3 (de)
ES (1)	ES2323864T3 (de)
IL (1)	IL177118A (de)
NO (1)	NO331190B1 (de)
PL (1)	PL219337B1 (de)
PT (1)	PT1559430E (de)
RU (1)	RU2368385C2 (de)
SG (1)	SG172727A1 (de)
SI (1)	SI1559430T1 (de)
WO (1)	WO2005074956A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100723609B1 (ko) *	2006-04-28	2007-06-04	주식회사 유유	신규한 조성의 알츠하이머형 치매 및 파킨슨씨병 예방 또는 치료용 은행잎 추출물, 그리고 은행잎으로부터의 추출 및 정제 방법
HUE041715T2 (hu) *	2007-12-21	2019-05-28	Dr Willmar Schwabe Gmbh & Co Kg	Ginkgo biloba levél-kivonat alkalmazása
ITTO20080532A1 (it) *	2008-07-10	2010-01-11	Euro Pharma S R L	Integratore dietetico atto al potenziamento neuronale e sensoriale
IT1397386B1 (it) *	2010-01-12	2013-01-10	Indena Spa	Composizioni a base di estratti di andrographis paniculata combinati con estratti di ginkgo biloba complessati con fosfolipidi e loro uso.
US8183227B1 (en)	2011-07-07	2012-05-22	Chemo S. A. France	Compositions, kits and methods for nutrition supplementation
US8168611B1 (en)	2011-09-29	2012-05-01	Chemo S.A. France	Compositions, kits and methods for nutrition supplementation
CN103156022B (zh) *	2011-12-09	2014-12-17	四川科伦药物研究有限公司	一种银杏叶保健茶及其制备方法
CN107249581B (zh) *	2014-11-20	2021-10-15	恩兹莫特克有限公司	用于改善沟通技能的磷脂制剂
EP3443965A4 (de)	2016-04-15	2020-02-19	Hirokawa, Yoshihiro	Mittel zur heilung der kognitiven funktion
CN105901649A (zh) *	2016-05-03	2016-08-31	王胜	一种含银杏提取物的植物盐及其制备方法
RU2680809C2 (ru) *	2016-12-20	2019-02-27	федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН)	Способ получения наноразмерной фитосомальной системы
US20200226948A1 (en) *	2019-01-14	2020-07-16	Robert Warren	Time and Attention Evaluation System
CN115066237A (zh) *	2020-01-03	2022-09-16	生物探索有限公司	用于治疗认知障碍的组合物
IT202300026307A1 (it)	2023-12-11	2025-06-11	Health Brands Lab S R L	Combinazione di nootropi per il benessere del sistema nervoso e dei processi cognitivi
CN118121640A (zh) *	2024-02-05	2024-06-04	联合理论有限公司	一种治疗儿童注意缺陷多动障碍的组合物、软胶囊及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2929959A1 (de) *	1979-07-24	1981-02-19	Hoechst Ag	Thermoplastische kunststoffmasse
IT1201149B (it) *	1987-01-14	1989-01-27	Indena Spa	Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IT1238684B (it) *	1990-02-09	1993-09-01	Indena Spa	Derivati del bilobalide,loro usi e formulazioni che li contegono
BR0016471A (pt) *	1999-12-17	2002-08-20		Combinação de ginseng e ginkgo para melhorar habilidades cognitivas
US6733797B1 (en) *	2000-11-15	2004-05-11	William K. Summers	Neuroceutical for improving memory and cognitive abilities
KR20020069539A (ko) *	2001-02-26	2002-09-05	주식회사 두산	뇌세포 보호용 조성물
US20040234544A1 (en) *	2001-08-09	2004-11-25	Ralf Jager	Formulation containing (lyso-)phosphatidylserine for the prevention and treatment of stress states in warm blooded animals
JP2003169632A (ja) *	2001-12-08	2003-06-17	Sapuri:Kk	米胚芽油、卵黄油及びホスファチジルセリン含有の健康食品
JP2003261456A (ja) *	2002-03-08	2003-09-16	Howaizu:Kk	脳の老化予防剤
US6572899B1 (en) *	2002-07-03	2003-06-03	Vitacost.Com, Inc.	Memory loss treatment formulation

2004
- 2004-01-29 AT AT04001937T patent/ATE428312T1/de active
- 2004-01-29 EP EP04001937A patent/EP1559430B1/de not_active Expired - Lifetime
- 2004-01-29 DE DE602004020574T patent/DE602004020574D1/de not_active Expired - Lifetime
- 2004-01-29 SI SI200431142T patent/SI1559430T1/sl unknown
- 2004-01-29 ES ES04001937T patent/ES2323864T3/es not_active Expired - Lifetime
- 2004-01-29 DK DK04001937T patent/DK1559430T3/da active
- 2004-01-29 PT PT04001937T patent/PT1559430E/pt unknown
2005
- 2005-01-26 CN CN2005800033273A patent/CN1913907B/zh not_active Expired - Lifetime
- 2005-01-26 US US10/587,468 patent/US8591965B2/en active Active
- 2005-01-26 JP JP2006550086A patent/JP5300196B2/ja not_active Expired - Lifetime
- 2005-01-26 RU RU2006127272/15A patent/RU2368385C2/ru active
- 2005-01-26 PL PL380826A patent/PL219337B1/pl unknown
- 2005-01-26 SG SG2011046141A patent/SG172727A1/en unknown
- 2005-01-26 CA CA2554760A patent/CA2554760C/en not_active Expired - Lifetime
- 2005-01-26 AU AU2005210091A patent/AU2005210091B2/en not_active Expired
- 2005-01-26 WO PCT/EP2005/000738 patent/WO2005074956A1/en not_active Ceased
- 2005-01-26 KR KR1020117024637A patent/KR101249667B1/ko not_active Expired - Lifetime
- 2005-01-26 KR KR1020067015129A patent/KR101249633B1/ko not_active Expired - Lifetime
2006
- 2006-07-27 IL IL177118A patent/IL177118A/en active IP Right Grant
- 2006-07-27 NO NO20063463A patent/NO331190B1/no unknown

Also Published As

Publication number	Publication date
US8591965B2 (en)	2013-11-26
PL219337B1 (pl)	2015-04-30
IL177118A (en)	2011-03-31
NO331190B1 (no)	2011-10-31
RU2006127272A (ru)	2008-02-10
HK1098380A1 (en)	2007-07-20
DE602004020574D1 (de)	2009-05-28
KR101249633B1 (ko)	2013-04-02
JP5300196B2 (ja)	2013-09-25
KR20060130148A (ko)	2006-12-18
NO20063463L (no)	2006-07-27
KR20110123289A (ko)	2011-11-14
KR101249667B1 (ko)	2013-04-02
SG172727A1 (en)	2011-07-28
EP1559430A1 (de)	2005-08-03
CA2554760A1 (en)	2005-08-18
PL380826A1 (pl)	2007-03-19
SI1559430T1 (sl)	2009-08-31
CN1913907B (zh)	2011-03-30
RU2368385C2 (ru)	2009-09-27
US20080226757A1 (en)	2008-09-18
DK1559430T3 (da)	2009-07-20
JP2007519668A (ja)	2007-07-19
WO2005074956A1 (en)	2005-08-18
PT1559430E (pt)	2009-06-16
CA2554760C (en)	2018-10-09
IL177118A0 (en)	2008-03-20
ES2323864T3 (es)	2009-07-27
AU2005210091B2 (en)	2010-06-03
CN1913907A (zh)	2007-02-14
EP1559430B1 (de)	2009-04-15
AU2005210091A1 (en)	2005-08-18

Legal Events

Date

Code

Title

Description

2009-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1559430

Country of ref document: EP

Publication	Publication Date	Title
DE602004020574D1 (de)	2009-05-28	Verwendung von Ginkgokomplexen zur Verbesserung von kognitiven Leistungen und Linderung der mentalen Ermüdung
BRPI0416799A (pt)	2007-03-06	sistema de orientação de sono e métodos relacionados
ATE495445T1 (de)	2011-01-15	Verfahren und zusammensetzungen in verbindung mit morbus alzheimer
DE60231804D1 (de)	2009-05-14	Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomöostase störungen
DE60204966D1 (de)	2005-08-11	Verwendung von cyclopamine zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis
Volkmar et al.	1999	Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry
ATE525114T1 (de)	2011-10-15	Kosmetikprodukt enthaltend ein bestandteil aus salmonidae-eierstockmembrane
DE60230961D1 (de)	2009-03-12	Verwendung einer dihydrochalcon-reichen phenolischen Fraktion für eine kosmetische Behandlung
ATE552251T1 (de)	2012-04-15	Thiophen- und furanverbindungen
DE60009145D1 (de)	2004-04-22	Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen
ATE325616T1 (de)	2006-06-15	Zusammensetzungen zur behandlung von angstzuständen und damit verbundenen erkrankungen
ATE408602T1 (de)	2008-10-15	Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen
PL1638559T3 (pl)	2010-06-30	Zastosowanie pirazolopirydyn w leczeniu deficytów poznawczych
Berg	2001	Psychiatric nurses' view of nursing care, clinical supervision and individualised care: Interventions on a dementia and on a general psychiatric ward.
DiBlasio et al.	2001	Effects of religiosity and forgiveness on violence among adolescents.
ATE291468T1 (de)	2005-04-15	Carnitin und huperzin enthaltende zusammensetzungen zur behandlung und vorbeugung von hyperaktivität mit aufmerksamkeitstörungen bei kindern
BR0212394A (pt)	2004-10-19	Artigo para limpeza, tratamento e/ou esfoliação da pele
Hale	1990	Sitting on memory's lap.
Hart	2009	Psychosynthesis: A Collection of Basic Writings/The Act of Will/The Primal Wound: A Transpersonal View of Trauma, Addiction, and Growth
Huntley et al.	2012	Practitioner's Perspective: Practicing Psychoanalytic and Experiential Therapies Today
Cheng	2016	Mind matters: How a dose of positive psychology helps dementia caregivers get through the day
Sarwar	2004	Starting Out
Pressler et al.	1998	Environmental intensity of the NICU based upon NIDCAP ratings
Lavigne et al.	2004	The Vancouver symposium: a unique focus on nerve damage and neuropathic trigeminal pain
DE50101673D1 (de)	2004-04-15	Verwendung von extrakten aus ginkgo biloba-blättern zur traumprovokation